Abstract
The question of re-irradiating the eye after ocular radiation is rarely raised, since the eye is irradiated infrequently as a primary target. Rather, significant efforts are made to minimize the dose received incidentally by the eye during treatment of tumors of the orbit or peri-orbital areas, or of other head and neck or central nervous system sites. CT-based 3D treatment planning is essential for treating these sites, and the eye itself, since availability of archived dosimetry data regarding previously administered irradiation is invaluable when considering re-irradiation of the eye, or of new or recurrent tumors involving the orbit or other adjacent sites. This chapter will discuss the need for radiation oncologists to be aware of the differing threshold doses for complications involving various parts of the eye, specifically the lens, optic nerve, macula, and retina, as well as the tolerance of the lacrimal gland and the tear-producing cells in the eyelids. Recommendations are provided for determining the advisability of attempting re-irradiation of the eye after primary treatment with low, intermediate, or high doses. Advantages of focused radiation therapy techniques, specifically external beam proton therapy and episcleral radionuclide plaque brachytherapy for primary treatment or for re-irradiation of discrete ocular tumors are discussed. Finally, results of two retrospective studies of proton beam re-irradiation of ocular melanomas are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Austin-Seymour M, Donaldson SS, Egbert PR et al (1985) Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys 11:371–379
Barak A, Hauser D, Yipp P et al (2005) A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration. Br J Radiol 78:827–831
Black LE, McCormick B, Abramson D (1996) External beam radiation therapy and retinoblastomas: long term results in the comparison of two techniques. Int J Radiat Oncol Biol Phys 35:45–51
Chan RV, Yonekawa Y, Lane AM et al (2010) Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica 224:209–216
Courdi A, Caujolle JP, Grange JD et al (2010) Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 45:5–11
Dendale R, Lumbroso-Le Rouic L, Noel G et al (2006) Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys 65:780–787
Dusenbery KE, Alul IH, Holland EJ et al (1992) Beta-irradiation of recurrent prerygia: results and complications. Int J Radiat Oncol Biol Phys 24:315–320
Egger E, Schalenbourg A, Zografos L et al (2001) Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 151:138–147
Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122
Ferry AP, Font R (1974) Carcinoma metastatic to the eye and orbit: a clinicopathological study of 227 eyes. Arch Ophthalmol 92:276–286
Fitzpatrick PJ, Macko S (1984) Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys 10:333–340
Gragoudas ES, Lane A (2005) Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am 18:111–118
Hernandez JC, Brady LW, Shields JA et al (1996) External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines. Int J Radiat Oncol Biol Phys 35:125–132
Hurbli T, Char DH, Harris J et al (1985) Radiation therapy for thyroid eye diseases. Am J Ophthalmol 99:633–637
Lanciano R, Fowble B, Sergott RC et al (1990) The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys 18:407–411
Marks LB, Bentel G, Sherouse GW et al (1993) Craniospinal irradiation for trilateral retinoblastoma following ocular irradiation. Med Dosim 18:125–128
Marucci L, Lane AM, Li W et al (2006) Conservation treatment of the eye: conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys 64:1018–1022
Marucci L, Ancukiewicz M, Lane AM et al (2010) Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiat Oncol Biol Phys [Epub ahead of print]
Merchant T, Gould CJ, Hilton NE et al (2002) Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma. J Pediatr Hematol Oncol 224:246–249
Parsons JT, Fitzpatrick CJ, Hood CL et al (1983) The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys 9:609–622
Paryani SB, Scotta WP, Wells JW et al (1994) Management of pterygium with surgery and radiation therapy. Int J Radiat Oncol Biol Phys 28:101–103
Petersen A, Kriss JP, Mc Dougall IR et al (1990) Prognostic factors in radiotherapy of Graves ophthalmopathy. Int J Radiat Oncol Biol Phys 19:259–264
Pradhan DG, Sandridge AL, Mullaney P et al (1997) Radiation therapy for retinoblastoma: a retrospective study of 120 patients. Int J Radiat Oncol Biol Phys 39:3–13
Quivey JM, Char DH, Phillips DL et al (1993) High intensity 125-Iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 26:613–618
Quivey JM, Augsberger J, Snelling L, Brady LW (1996) I-125 plaque therapy for uveal melanoma: analysis of the impact of time and dose factors on local control. Cancer 77:2356–2362
Rudoler SB, Shields CL, Corn BW et al (1997) Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients. J Clin Oncol 15:1244–1251
Tsina EK, Lane AM, Zacks DN et al (1997) Treatment of metastatic tumors of the choroid with proton beam irradiation. Ophthalmology 112:337–343
Van den Brenk HA (1968) Results of prophylactic postoperative irradiation in 1300 cases of pterygium. Am J Roentgenol 103:723–727
Van Houtte P, Roelandts M, Devriendt D et al (2005) Radiation therapy of benign diseases. What’s new eight years after? Cancer Radiother 9:427–434
Wilder RB, Buatti JM, Kittleson JM et al (1992) Pterygium treated with excision and postoperative beta irradiation. Int J Radiat Oncol Biol Phys 23:533–537
Zambarakji HJ, Lane AM, Ezra E et al (2006) Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology 113:2012–2019
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Munzenrider, J.E. (2011). Eye Tumors. In: Nieder, C., Langendijk, J. (eds) Re-irradiation: New Frontiers. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2010_107
Download citation
DOI: https://doi.org/10.1007/174_2010_107
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12467-9
Online ISBN: 978-3-642-12468-6
eBook Packages: MedicineMedicine (R0)